[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

West Pharmaceutical Looks Set to Deliver Again, but Margin Questions Linger

West Pharmaceutical Services (WST) reports second-quarter 2026 earnings before the market opens on July 23, 2026, with analysts expecting $2.08 per share—a significant acceleration from the $1.84 reported in the same quarter last year. The central question: can the pharmaceutical packaging and delivery systems leader sustain its remarkable streak of double-digit earnings beats while navigating evolving demand dynamics in the biopharma sector? With the stock trading near all-time highs and Wall Street maintaining near-unanimous bullish conviction, this report will test whether WST's momentum can continue or if expectations have finally caught up to reality.

Fundamentals

See More
  • Market Capitalization, $K 25,320,950
  • Shares Outstanding, K 70,648
  • Annual Sales, $ 3,074 M
  • Annual Income, $ 493,700 K
  • EBIT $ 655 M
  • EBITDA $ 826 M
  • 60-Month Beta 1.16
  • Price/Sales 8.26
  • Price/Cash Flow 36.89
  • Price/Book 8.49

Options Overview Details

View History
  • Implied Volatility 31.17% (-14.77%)
  • Historical Volatility 18.90%
  • IV Percentile 29%
  • IV Rank 20.20%
  • IV High 59.00% on 02/11/26
  • IV Low 24.12% on 12/08/25
  • Expected Move (DTE 29) 22.27 (6.18%)
  • Put/Call Vol Ratio 0.55
  • Today's Volume 428
  • Volume Avg (30-Day) 129
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 4,888
  • Open Int (30-Day) 4,369
  • Expected Range 338.00 to 382.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.08
  • Number of Estimates 6
  • High Estimate $2.10
  • Low Estimate $2.06
  • Prior Year $1.84
  • Growth Rate Est. (year over year) +13.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
335.72 +7.79%
on 06/24/26
386.00 -6.25%
on 07/23/26
+25.49 (+7.58%)
since 06/23/26
3-Month
290.41 +24.61%
on 04/28/26
386.00 -6.25%
on 07/23/26
+52.18 (+16.85%)
since 04/23/26
52-Week
223.83 +61.68%
on 01/30/26
386.00 -6.25%
on 07/23/26
+134.58 (+59.20%)
since 07/23/25

Most Recent Stories

More News
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

WST : 362.26 (+1.07%)
West Pharmaceutical: Q2 Earnings Snapshot

West Pharmaceutical: Q2 Earnings Snapshot

WST : 362.26 (+1.07%)
West Pharmaceutical Looks Set to Deliver Again, but Margin Questions Linger

Barchart Research What to Expect from WST Earnings WST Generated July 22, 2026 Current Price $358.41 EPS Estimate $$2.08 Consensus Rating Strong Buy Average Move 14.89% West Pharmaceutical Looks Set to...

WST : 362.26 (+1.07%)
West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For

West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For

WST : 362.26 (+1.07%)
West Declares Quarterly Dividend

EXTON, Pa. , July 21, 2026 /PRNewswire/ -- On July 21, 2026, the Board of Directors of  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable...

WST : 362.26 (+1.07%)
3 Reasons WST is Risky and 1 Stock to Buy Instead

3 Reasons WST is Risky and 1 Stock to Buy Instead

WST : 362.26 (+1.07%)
West to Host Second-Quarter 2026 Conference Call

EXTON, Pa. , July 7, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...

WST : 362.26 (+1.07%)
What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report

West Pharmaceutical Services will release its second-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.

XLV : 160.87 (+0.90%)
$SPX : 7,410.29 (-1.18%)
WST : 362.26 (+1.07%)
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System

EXTON, Pa. , July 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the company completed...

WST : 362.26 (+1.07%)
1 High-Flying Stock Worth Your Attention and 2 Facing Challenges

1 High-Flying Stock Worth Your Attention and 2 Facing Challenges

WST : 362.26 (+1.07%)
MOG.A : 408.82 (+1.47%)
KTOS : 49.57 (+3.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical...

See More

Key Turning Points

3rd Resistance Point 369.28
2nd Resistance Point 366.26
1st Resistance Point 362.33
Last Price 362.26
1st Support Level 355.38
2nd Support Level 352.36
3rd Support Level 348.43

See More

52-Week High 386.00
Last Price 362.26
Fibonacci 61.8% 324.05
Fibonacci 50% 304.92
Fibonacci 38.2% 285.78
52-Week Low 223.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.